Park Place Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09K | Hold |
66
| – | – | ﹤0.01% | 658 |
|
|
2025
Q1 | $4.78K | Sell |
66
-2
| -3% | -$145 | ﹤0.01% | 669 |
|
|
2024
Q4 | $5.03K | Sell |
68
-30
| -31% | -$2.22K | ﹤0.01% | 669 |
|
|
2024
Q3 | $6.47K | Sell |
98
-181
| -65% | -$11.9K | ﹤0.01% | 681 |
|
|
2024
Q2 | $25.8K | Sell |
279
-1,085
| -80% | -$100K | 0.01% | 458 |
|
|
2024
Q1 | $130K | Sell |
1,364
-1,353
| -50% | -$129K | 0.05% | 285 |
|
|
2023
Q4 | $207K | Sell |
2,717
-1,222
| -31% | -$93.2K | 0.08% | 216 |
|
|
2023
Q3 | $273K | Sell |
3,939
-120
| -3% | -$8.31K | 0.08% | 200 |
|
|
2023
Q2 | $383K | Sell |
4,059
-745
| -16% | -$70.3K | 0.11% | 171 |
|
|
2023
Q1 | $397K | Sell |
4,804
-470
| -9% | -$38.9K | 0.11% | 171 |
|
|
2022
Q4 | $393K | Buy |
+5,274
| New | +$393K | 0.11% | 171 |
|